Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.

Model and dose uncertainty highly influence the accuracy of model-based patient selection for proton therapy. A reduction of NTCP-model uncertainty is necessary to reach more accurate model-based patient selection.